PWE-037 Panenteric Capsule Endoscopy: An Alternative Non-invasive Tool To Screen For Idiopathic Inflammatory Bowel Disease (ibd)

Abstract

complications (bleeding/pain) were analysed. Pearson chisquare tests were used to compare experiences by gender, high vs. low levels of socioeconomic deprivation (using Index of Multiple Deprivation scores), and whether patients reported receiving sedation or not. Results After excluding patients outside the target date range and those who did not have colonoscopy, 76,717 patients were eligible for analysis, of whom 60,581 (79.0%) responded to the questionnaire. Nearly all patients felt they understood the risks (95.7%) and benefits (98.2%) of the test, and 97.8% felt the preparation instructions were clear. Comparison by gender and deprivation did not yield clinically meaningful (≥3%) differences. In terms of the hospital experience, virtually all patients felt they were treated with respect (98.5%) and had privacy (98.0%), but 20.8% experienced more discomfort than expected (although only 5.2% asked for the test to be stopped/paused). Procedural discomfort was moderated by gender, with more women than men reporting higher-thanexpected discomfort (25.4% vs. 17.9%; p < 0.0005), and requesting that the test be stopped/paused (7.1% vs. 3.9%; p < 0.0005). Use of sedation showed only a weak association with patient experience: 22.2% of sedated vs. 20.2% of nonsedated patients reported unexpected discomfort; 6.4% vs. 4.8% asked for the test to be stopped/paused; both p-values <0.0005). Post-test, 14.3% of patients reported pain and 6.9% reported rectal bleeding. Pain was more common in women (18.0% vs. 11.9%; p < 0.0005) but there were no other clinically meaningful differences post-test related to gender or deprivation level. Conclusion Most patients referred for colonoscopy as part of the Bowel Cancer Screening Programme have a positive colonoscopy experience. The most negative aspect of the experience was the test being unexpectedly uncomfortable. Patients are extensively counselled pre-procedure but more emphasis on managing expectations, along with continued measures to reduce discomfort and pain are required, particularly for women.

Colon capsule endoscopy for inflammatory bowel disease

“…To date, five studies have evaluated the performance of CCE‐2 with ileo‐colonoscopy or small bowel CE in suspected or confirmed CD (Table ). There are also studies that evaluated the role of CCE in routine clinical practice without comparing with a reference standard, in postoperative CD, and in CD patients who refused or had incomplete colonoscopy . The first multicenter European study has reported that CCE‐2 has a comparable sensitivity of 86% but a low specificity of 40% for ileo‐colonic ulceration in active CD .…”